We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+77.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
-$17.5M
Cap. Flow
-$2.25M
Cap. Flow %
-2.19%
Top 10 Hldgs %
35.28%
Holding
169
New
46
Increased
35
Reduced
35
Closed
32

Top Buys

Rank Stock Value
1
DRVN icon
Driven Brands
DRVN
+$8.81M
2
RVMD icon
Revolution Medicines
RVMD
+$6.74M
3
ICLR icon
Icon
ICLR
+$2.42M
4
TRIP icon
TripAdvisor
TRIP
+$2.21M
5
ELME
Elme Communities
ELME
+$2.17M

Top Sells

Rank Stock Value
1
GDEN
Golden Entertainment
GDEN
+$5.71M
2
CLMT icon
Calumet Specialty Products
CLMT
+$5.34M
3
WBD icon
Warner Bros
WBD
+$4.62M
4
RNAM
Avidity Biosciences
RNAM
+$3.9M
5
RPTX
Repare Therapeutics
RPTX
+$3.35M

Sector Composition

Rank Sector Weight
1 Healthcare 29.22%
2 Consumer Discretionary 17.78%
3 Real Estate 12.14%
4 Financials 8.26%
5 Technology 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMXI icon
101
International Money Express
IMXI
$386M
$158K 0.15%
10,000
– –
MLAC
102
DELISTED
Mountain Lake Acquisition Corp
MLAC
$158K 0.15%
+15,000
New +$157K
PD icon
103
PagerDuty
PD
$753M
$155K 0.15%
+25,000
New +$216K
DBRG icon
104
DigitalBridge
DBRG
$2.93B
$154K 0.15%
10,000
-3,800
-28% -$58.5K
NKTX icon
105
Nkarta
NKTX
$162M
$143K 0.14%
68,000
+35,922
+112% +$80.4K
SHC icon
106
Sotera Health
SHC
$4.92B
$143K 0.14%
+10,000
New +$166K
RTAC
107
Renatus Tactical Acquisition Corp I
RTAC
$326M
$129K 0.12%
+35,782
New +$378K
DDL
108
Dingdong
DDL
$523M
$129K 0.12%
+50,000
New +$139K
HCMA
109
HCM III Acquisition Corp
HCMA
$346M
$126K 0.12%
12,530
-1,516
-11% -$15.4K
SPKL
110
Spark I Acquisition Corp
SPKL
$101M
$122K 0.12%
10,813
– –
RZLT icon
111
Rezolute
RZLT
$476M
$122K 0.12%
40,000
-38,200
-49% -$115K
PEPG icon
112
PepGen
PEPG
$131M
$121K 0.12%
68,096
+31,896
+88% +$179K
TWO
113
Two Harbors Investment
TWO
$1.27B
$114K 0.11%
+10,000
New +$112K
CPAC
114
Cementos Pacasmayo
CPAC
$1.03B
$112K 0.11%
11,221
-779
-6% -$8.2K
MREO
115
Mereo BioPharma
MREO
$48.2M
$109K 0.11%
329,200
-34,800
-10% -$14.9K
RAAQ
116
DELISTED
Real Asset Acquisition Corp
RAAQ
$105K 0.1%
10,000
– –
SZZL
117
Sizzle Acquisition Corp II
SZZL
$325M
$103K 0.1%
+10,000
New +$102K
CCII
118
Cohen Circle Acquisition Corp II
CCII
$359M
$102K 0.1%
10,000
-10,809
-52% -$111K
KYIV
119
Kyivstar Group
KYIV
$3.15B
$101K 0.1%
+10,000
New +$118K
BRNS
120
Barinthus Biotherapeutics
BRNS
$24.6M
$90.7K 0.09%
159,465
+75,024
+89% +$49.4K
FTW
121
Presidio Production Co
FTW
$344M
$85.1K 0.08%
+100,000
New +$1.11M
PMVP icon
122
PMV Pharmaceuticals
PMVP
$62.9M
$82.9K 0.08%
66,846
+21,346
+47% +$27.1K
ABOS icon
123
Acumen Pharmaceuticals
ABOS
$159M
$82.6K 0.08%
+35,000
New +$89.3K
DOMO icon
124
Domo
DOMO
$161M
$79.6K 0.08%
+26,000
New +$132K
SITC icon
125
SITE Centers
SITC
$232M
$75.6K 0.07%
14,000
– –
3 4
5
6 7

Similar funds

EFT
Envision Financial Transparency Greensboro, North Carolina $103M AUM
GWL
Generations Wealth LLC Mason, Ohio $103M AUM
CC
Caspian Capital New York $103M AUM
ABLA
Alan B. Lancz & Associates Toledo, Ohio $103M AUM 31.99% 1-Year Est. Return
SPCM
Stoic Point Capital Management Palo Alto, California $103M AUM
OPAM
Olympus Peak Asset Management Greenwich, Connecticut $103M AUM 58.06% 1-Year Est. Return
ES
ETF Store Overland Park, Kansas $103M AUM 15.78% 1-Year Est. Return
IMT
Investment Management Trust Fitchburg, Massachusetts $103M AUM

Rangeley Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Rangeley Capital held 169 positions worth $103M, down 15% from $120M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Rangeley Capital's Q1 2026 filing shows 46 new, 35 increased, 35 reduced and 32 closed positions. Its largest new stake was Driven Brands: 625,500 shares worth $7.89M. The largest sale was Golden Entertainment, an estimated $5.71M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Real Estate.

  • Rangeley Capital's largest Q1 2026 buy was Driven Brands: 625,500 shares worth $7.89M.
  • Rangeley Capital added most to Janux Therapeutics in Q1 2026, an estimated $1.33M increase.
  • Rangeley Capital's biggest Q1 2026 reduction was Calumet Specialty Products, cutting an estimated $5.34M.
  • Rangeley Capital fully exited Golden Entertainment in Q1 2026, selling an estimated $5.71M.
  • Rangeley Capital's ten largest holdings make up 35% of its $103M portfolio in Q1 2026.
  • Rangeley Capital opened 46 new positions and closed 32 in Q1 2026.
  • Rangeley Capital's portfolio value fell 15% quarter-over-quarter to $103M.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.